Detected ·
En Carta Diagnostics
€5M—
En Carta Diagnostics, a deep-tech startup developing a rapid molecular diagnostic platform for Lyme disease, raised €5M in a seed round led by Blue Forest Ventures, with participation from Ring Capital (Generations fund), CentraleSupélec Venture, 50 Partners Health, and business angels.
- Website
- www.encarta.bio
- Amount
- €5 000 000 EUR
- Stage
- —
- Event
- Funding round
- Detected
- 2026-07-10 12:06:47 UTC
- Signal ID
- 02199d8b-c698-4732-8ad2-3b4a7dc9e74b
As the API returns it
{
"id": "02199d8b-c698-4732-8ad2-3b4a7dc9e74b",
"created_at": "2026-07-10T12:06:47.639018Z",
"company_name": "En Carta Diagnostics",
"company_website_url": "www.encarta.bio",
"company_linkedin_url": "https://www.linkedin.com/company/en-carta-diagnostics",
"event_type": "funding",
"funding_amount": 5000000,
"funding_currency": "EUR",
"funding_stage": null,
"message": "*En Carta Diagnostics, a deep-tech startup developing a rapid molecular diagnostic platform for Lyme disease, raised €5M in a seed round led by Blue Forest Ventures, with participation from Ring Capital (Generations fund), CentraleSupélec Venture, 50 Partners Health, and business angels.*"
}